Paolo Bossi Selected Research

Benzydamine (Tantum)

10/2021	The role of benzydamine in prevention and treatment of chemoradiotherapy-induced mucositis.
10/2019	Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients and clinical practice guidelines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paolo Bossi Research Topics

Disease

74	Neoplasms (Cancer) 06/2022 - 05/2004
46	Head and Neck Neoplasms (Head and Neck Cancer) 03/2022 - 11/2007
30	Squamous Cell Carcinoma of Head and Neck 06/2022 - 11/2006
19	Stomatitis 10/2021 - 11/2013
14	Mucositis 01/2022 - 02/2012
11	Pain (Aches) 01/2022 - 07/2014
9	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2022 - 03/2009
8	Carcinoma (Carcinomatosis) 10/2022 - 11/2009
7	Squamous Cell Neoplasms (Squamous Cell Cancer) 12/2019 - 07/2008
6	Nasopharyngeal Carcinoma 12/2021 - 01/2004
6	Oropharyngeal Neoplasms 01/2021 - 12/2006
6	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2020 - 01/2004
5	Cancer Pain 01/2022 - 05/2014
5	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2017
5	Salivary Gland Neoplasms (Salivary Gland Cancer) 12/2021 - 05/2004
4	Adenoid Cystic Carcinoma (Cylindroma) 01/2022 - 10/2005
4	Disease Progression 01/2022 - 01/2018
4	Fatigue 12/2021 - 10/2013
4	Nausea 02/2020 - 11/2015
4	Deglutition Disorders (Dysphagia) 01/2020 - 11/2015
3	COVID-19 01/2022 - 01/2020
3	Hypoxia (Hypoxemia) 01/2022 - 04/2015
3	Xerostomia 07/2021 - 06/2016
3	Adenocarcinoma 12/2020 - 06/2014
3	Dermatitis 08/2020 - 10/2015
3	Vomiting 02/2020 - 11/2015
2	Neutropenia 01/2021 - 11/2016
2	Virus Diseases (Viral Diseases) 01/2020 - 01/2020
2	Diarrhea 10/2019 - 10/2013
2	Basal Cell Carcinoma (Rodent Ulcer) 01/2018 - 02/2015
2	Paranasal Sinus Neoplasms 02/2016 - 12/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2022
1	Infections 01/2022
1	Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma) 01/2022
1	Supraventricular Tachycardia 12/2021
1	Flushing 12/2021
1	Sinonasal undifferentiated carcinoma 12/2021
1	Lung Diseases (Lung Disease) 12/2021
1	Mouth Neoplasms (Oral Cancer) 07/2021

Drug/Important Bio-Agent (IBA)

12	PlatinumIBA 01/2022 - 10/2005
11	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2004
11	Cetuximab (Erbitux)FDA Link 12/2019 - 10/2005
10	Biological ProductsIBA 01/2022 - 12/2006
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2006
7	Opioid Analgesics (Opioids)IBA 01/2022 - 05/2014
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 11/2006
6	Fluorouracil (Carac)FDA LinkGeneric 12/2020 - 01/2004
5	Pharmaceutical PreparationsIBA 12/2021 - 01/2016
4	Androgen Receptors (Androgen Receptor)IBA 12/2021 - 05/2004
4	Analgesics (Analgesic Drugs)IBA 05/2020 - 11/2013
3	AndrogensIBA 12/2021 - 06/2014
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2020
3	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2017
3	Fentanyl (Sublimaze)FDA LinkGeneric 05/2020 - 09/2014
3	Anesthetics (Anesthetic Agents)IBA 05/2020 - 11/2013
2	cemiplimabIBA 05/2022 - 11/2021
2	Vitamin D FDA LinkGeneric 01/2022 - 09/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 01/2016
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021 - 01/2021
2	Immune Checkpoint InhibitorsIBA 11/2021 - 01/2020
2	Benzydamine (Tantum)IBA 10/2021 - 10/2019
2	TabletsIBA 07/2021 - 01/2020
2	VitaminsIBA 07/2021 - 10/2019
2	Chewing Gum (Chewing Gums)IBA 07/2021 - 05/2020
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 02/2020
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021 - 02/2020
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 05/2020
2	Leucovorin (Folinic Acid)FDA Link 12/2020 - 01/2020
2	CytokinesIBA 05/2020 - 12/2016
2	AntiemeticsIBA 02/2020 - 11/2015
2	lenvatinibIBA 01/2020 - 04/2018
2	Phosphotransferases (Kinase)IBA 01/2020 - 04/2018
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 01/2017
2	HhAntag691IBA 01/2018 - 02/2015
2	Monoclonal AntibodiesIBA 01/2018 - 11/2017
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2022
1	ElementsIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	TESIBA 01/2022
1	somatostatin receptor 2IBA 01/2022
1	Abiraterone AcetateIBA 12/2021

Therapy/Procedure

47	Therapeutics 03/2022 - 06/2014
46	Radiotherapy 10/2022 - 01/2004
40	Drug Therapy (Chemotherapy) 01/2022 - 01/2004
16	Chemoradiotherapy 10/2021 - 11/2009
12	Immunotherapy 06/2022 - 04/2018
8	Induction Chemotherapy 02/2022 - 11/2015
7	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 02/2020 - 05/2004
4	Nutritional Support (Artificial Feeding) 03/2022 - 07/2014
3	Pain Management 01/2022 - 08/2018
3	Combined Modality Therapy 01/2019 - 12/2015
2	Adjuvant Radiotherapy 01/2022 - 01/2022
2	Neoadjuvant Therapy 12/2020 - 02/2010
2	Precision Medicine 10/2020 - 01/2020
2	Aftercare (After-Treatment) 01/2018 - 12/2016
2	Chemoprevention 02/2015 - 07/2008
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Length of Stay 01/2022
1	Analgesia 01/2022
1	Castration 12/2021